
Portugal · Pharmaceuticals startup
AceCann is a Portuguese medical cannabis company established in 2019, focused on the organic cultivation, processing, and extraction of premium medical cannabis products for the Eu
Funding reportedLast round: Seed
Follow AceCann and see its new rounds in your feed.Start following
AceCann is a Portuguese medical cannabis company established in 2019, focused on the organic cultivation, processing, and extraction of premium medical cannabis products for the Eu
ropean healthcare market. Based in Lisbon, the company operates a modern production facility in Vendas Novas, utilizing advanced indoor farming technology and solvent-free extraction methods to ensure pharmaceutical-grade quality. The company offers standardized medical cannabis flowers and extracts that meet EU-GMP and GACP standards. AceCann is dedicated to improving patient lives through high-quality, innovative products and conducts research and development for medical cannabis applications. Its target customers include pharmaceutical distributors and healthcare providers across Europe, operating under a B2B business model. With a commitment to sustainable practices, AceCann aims to distinguish itself in the growing medical cannabis market.
Funding, as reported
From AceCann's own website: 10 on the team.
AdvisersChris MayleMarc Gare
What they build
Known for
pharmaceutical manufacturinggacp cultivationmedical cannabismedicalquality assurancecontract manufacturingmechanical or industrial engineeringservicessolventless extractioneugmp manufacturingpharmaceuticalsindoor cannabis productionpharmaceuticalgrade productionb2b
Built with from their website
Microsoft Email ProvidersGoDaddy HostingjsDelivrcdnjsBootstrapGoDaddy DomainsOpen GraphMicrosoft ExchangeNginxjQuery
PWASlickMicrosoft 365WOWMicrosoft Exchange OnlineUnpkgOutlookCloudFlare
Add your raise, your deck and your story, and put AceCann in front of investors. Or tell us what we have wrong.